You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BLTE Sale Disclosure
Lin Yu-hsin · SEC Form 4 · Filed Aug 14, 2026
Sale
Calculated transaction value
$25.56K
Lin Yu-hsin Chief Executive Officer
BLTE
Belite Bio, Inc
BLTE
Transaction date
Aug 12, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 2 days later
BLTE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- American depositary share
- Quantity / price
- 142 shares @ $180
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-350217
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$65.83K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Belite Bio, Inc BLTE Current | Sale | Aug 12, 2026 | $25.56K |
| Belite Bio, Inc BLTE | Sale | Aug 12, 2026 | $40.27K |